TRIPTORELIN PAMOATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for triptorelin pamoate and what is the scope of freedom to operate?

Triptorelin pamoate is the generic ingredient in two branded drugs marketed by Azurity and Verity, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Triptorelin pamoate has forty-six patent family members in thirty-one countries.

There are two drug master file entries for triptorelin pamoate. Two suppliers are listed for this compound.

Summary for TRIPTORELIN PAMOATE

International Patents:	46
US Patents:	1
Tradenames:	2
Applicants:	2
NDAs:	4
Drug Master File Entries:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	56
Clinical Trials:	17
Patent Applications:	6,823
What excipients (inactive ingredients) are in TRIPTORELIN PAMOATE?	TRIPTORELIN PAMOATE excipients list
DailyMed Link:	TRIPTORELIN PAMOATE at DailyMed

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for TRIPTORELIN PAMOATE

Generic Entry Date for TRIPTORELIN PAMOATE^: ⤷ Sign Up* Constraining patent/regulatory exclusivity: ⤷ Sign Up Dosage: INJECTABLE;INTRAMUSCULAR

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for TRIPTORELIN PAMOATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Cancer Research Antwerp	Phase 2
Janssen Pharmaceutica	Phase 2
Stanford University	Phase 1/Phase 2

See all TRIPTORELIN PAMOATE clinical trials

Medical Subject Heading (MeSH) Categories for TRIPTORELIN PAMOATE

Antineoplastic Agents, Hormonal
Luteolytic Agents

Anatomical Therapeutic Chemical (ATC) Classes for TRIPTORELIN PAMOATE

L02AE	Gonadotropin releasing hormone analogues
L02A	HORMONES AND RELATED AGENTS
L02	ENDOCRINE THERAPY
L	Antineoplastic and immunomodulating agents

US Patents and Regulatory Information for TRIPTORELIN PAMOATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Verity	TRELSTAR	triptorelin pamoate	INJECTABLE;INTRAMUSCULAR	021288-001	Jun 29, 2001		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Azurity	TRIPTODUR KIT	triptorelin pamoate	FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR	208956-001	Jun 29, 2017		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Verity	TRELSTAR	triptorelin pamoate	INJECTABLE;INTRAMUSCULAR	020715-001	Jun 15, 2000		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Azurity	TRIPTODUR KIT	triptorelin pamoate	FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR	208956-001	Jun 29, 2017		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Verity	TRELSTAR	triptorelin pamoate	INJECTABLE;INTRAMUSCULAR	022437-001	Mar 10, 2010		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TRIPTORELIN PAMOATE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Verity	TRELSTAR	triptorelin pamoate	INJECTABLE;INTRAMUSCULAR	020715-001	Jun 15, 2000	⤷ Sign Up	⤷ Sign Up
Verity	TRELSTAR	triptorelin pamoate	INJECTABLE;INTRAMUSCULAR	020715-001	Jun 15, 2000	⤷ Sign Up	⤷ Sign Up
Verity	TRELSTAR	triptorelin pamoate	INJECTABLE;INTRAMUSCULAR	021288-001	Jun 29, 2001	⤷ Sign Up	⤷ Sign Up
Verity	TRELSTAR	triptorelin pamoate	INJECTABLE;INTRAMUSCULAR	022437-001	Mar 10, 2010	⤷ Sign Up	⤷ Sign Up
Verity	TRELSTAR	triptorelin pamoate	INJECTABLE;INTRAMUSCULAR	021288-001	Jun 29, 2001	⤷ Sign Up	⤷ Sign Up
Verity	TRELSTAR	triptorelin pamoate	INJECTABLE;INTRAMUSCULAR	021288-001	Jun 29, 2001	⤷ Sign Up	⤷ Sign Up
Verity	TRELSTAR	triptorelin pamoate	INJECTABLE;INTRAMUSCULAR	020715-001	Jun 15, 2000	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for TRIPTORELIN PAMOATE

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Colombia	6251234	COMPOSICIONES QUE COMPRENDEN MICROPARTICULAS DE UN COPOLIMERO DE ACIDO LACTICO Y GLICOLICO (PLGA) CON UNA SUSTANCIA ACTIVA EN LA FORMA DE UNA SAL PEPTIDICA INSOLUBLE	⤷ Sign Up
Portugal	2500014		⤷ Sign Up
Morocco	31422	COMPOSITION PHARMACEUTIQUE A LIBERATION PROLONGEE CONSTITUEE DE MICROPARTICULES	⤷ Sign Up
Serbia	55591	FARMACEUTSKA KOMPOZICIJA SA SPORIM OSLOBAĐANJEM PRIPREMLJENA OD MIKROČESTICA (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES)	⤷ Sign Up
Hungary	E031550		⤷ Sign Up
Croatia	P20181854		⤷ Sign Up
Croatia	P20161785		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.